Skip to main content
Alexander J Keeley on Muck Rack

Alexander J Keeley

As seen in: Nature, MDPI, Thorax, The Lancet, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexander J

Contact Alexander J, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting | Nature Medicine

|
By Alexander J Keeley, Alana L. Whitcombe, Martina Carducci, Elena Boero, Danilo Gomes Moriel, Nicole J Moreland, Beate Kampmann, Henrik Salje
| Nature Verified
Correction to: Nature Medicine https://doi.org/10.1038/s41591-025-03868-4, published online 8 August 2025. In the version of the article initially published, in the “Early-life serological profiles” section, the text “…two or more antigens of greater than 0.5 log10 RLU ml−1” should have read “…two or more antigens or greater than 0.5 log10 RLU ml−1”.
Open in Who Shared Issue with article?

Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting - Nature Medicine Original

|
By Alexander J Keeley, Alana L. Whitcombe, Martina Carducci, Nicole J Moreland, Beate Kampmann, Henrik Salje, Elena Boero, Danilo Gomes Moriel
| Nature Verified
Abstract Streptococcus pyogenes leads to 500,000 deaths annually, many due to rheumatic heart disease in low-income settings. Limited understanding of natural protective immunity to S. pyogenes hinders vaccine development. Here we describe the evolution of serological profiles to conserved vaccine antigens and serotype-specific M proteins from birth and throughout the life course in The Gambia.
Open in Who Shared View Duplicates (2) Issue with article?

Early life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high burden setting

|
By Alexander J Keeley, Fatoumata Camara, Edwin P Armitage, Gabrielle De Crombrugghe
| medRxiv
AJK received training in immunoassay development and delivery from GSK Vaccines Institute for Global Health (GVGH), an affiliate of GSK. GSK had no role in overall study design, data analysis, nor data interpretation for this study. OR MC EB LR LM, MI, DGM are employees of GSK Vaccines. AB and PRS are inventors on a submitted patent related to Streptococcus pyogenes vaccines. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Open in Who Shared Issue with article?
See all 9 articles